Novosanis (exit 7.01.2019)

Novosanis designs and develops medical devices for a variety of applications, ranging from injection appliances to in vitro diagnostics. Our goal is to improve health and patient care and offer a better quality of life through sustainable technologies. Novosanis is a newly founded spin-off company of the University of Antwerp.

The company currently has two devices in development: VAX-ID, suited for intradermal injections, and Colli-Pee, suited for collection of first void urine.